Protagonist Therapeutics Inc buy Wolfe Research
Start price
21.05.26
/
50%
€88.00
Target price
21.05.27
€116.17
Performance (%)
37.50%
Price
09.07.26
€121.00
Summary
This prediction is currently active. With a performance of 37.50% the BUY prediction by Wolfe_Research is a big success. This prediction currently runs until 21.05.27. The prediction end date can be changed by Wolfe_Research at any time. Wolfe_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 4.310% | 4.310% |
| iShares Core DAX® | -1.779% | 2.475% |
| iShares Nasdaq 100 | 1.522% | 3.290% |
| iShares Nikkei 225® | 1.083% | 7.039% |
| iShares S&P 500 | 0.929% | 3.254% |
Comments by Wolfe_Research for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) is now covered by Wolfe Research. They set an "outperform" rating and a $135.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Wolfe_Research for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€84.00
22.05.26
22.05.26
-
22.05.27
22.05.27
44.05%
09.07.26
09.07.26
